Contract 19AQMM26F7050
Mckesson Corporation · Department Of State · February 9, 2026
Mckesson Corporation was awarded a federal contract by Department Of State on February 9, 2026 for an undisclosed amount of work in pharmaceutical preparation manufacturing. Performance is in Doral, FL. This is a task or delivery order issued under parent IDIQ 19AQMM26A0296. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 12, 2026. If all options are exercised, the contract could reach $15.00 million.
Contract details
- PIID
- 19AQMM26F7050
- Parent IDIQ
- 19AQMM26A0296
- Award type
- Bpa Call
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Replenishable Field Medical Sets, Kits, And Outfits
- Place of performance
- Doral, FL
- First action
- February 9, 2026
- Latest action
- March 12, 2026
Description
MEDICAL: SURGICAL MEDICAL SUPPLIES - UPDATE ACCOUNTING LINE DETAILS ITEM 1 ACCOUNTING LINE 1
Modification timeline
-
March 12, 2026Mod P00002 · Other Administrative Action$0
-
February 9, 2026Base awardMEDICAL: SURGICAL MEDICAL SUPPLIES$0
-
February 9, 2026Mod P00001 · Other Administrative ActionMEDICAL: SURGICAL MEDICAL SUPPLIES - REMOVE TERMS AND CONDITIONS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Mckesson Corporation | Department Of State | February 9, 2026 | $0 |
| Project Services International Corporation, Inc | Department Of State | February 6, 2026 | $18.2K |
| Miscellaneous Foreign Awardees | Department Of State | January 28, 2026 | $0 |
| Miscellaneous Foreign Awardees | Department Of State | September 23, 2025 | $0 |
| Glaxosmithkline, Llc | Department Of State | September 9, 2025 | $667.6K |
| Sanofi Vaccines Us Inc. | Department Of State | September 9, 2025 | $176.6K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 19AQMM26F7050?
Contract 19AQMM26F7050 is a federal contract awarded to Mckesson Corporation by Department Of State on February 9, 2026 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 19AQMM26F7050?
Mckesson Corporation won contract 19AQMM26F7050 from Department Of State.
How much is contract 19AQMM26F7050 worth?
Contract 19AQMM26F7050 has obligated $0 to date but carries a potential ceiling of $15.00 million if fully funded and all options are exercised.